Laboratory-Grade Cefixime Research Overview
Ceff DT 250 mg is a third-generation cephalosporin antibiotic compound manufactured by Lupin for laboratory research applications. This broad-spectrum beta-lactam antibiotic demonstrates potent activity against gram-positive and gram-negative bacterial strains in microbiological studies. Researchers investigating bacterial resistance mechanisms, antimicrobial susceptibility testing, and pharmaceutical development processes utilise this compound for comprehensive in-vitro analysis. The 250mg tablet formulation provides standardised concentrations for consistent experimental protocols across multiple research studies.
Scientific investigators studying antibiotic mechanisms examine cefixime’s ability to inhibit bacterial cell wall synthesis through beta-lactam ring interaction with penicillin-binding proteins. This compound serves as a valuable reference standard in pharmaceutical research laboratories conducting antimicrobial efficacy studies. Research teams at Stroid UK Shop can access pharmaceutical-grade compounds for advanced laboratory investigations requiring precise molecular characterisation and biological activity assessment.
Microbiological Research Applications
Laboratory researchers investigate cefixime’s broad antimicrobial spectrum against various pathogenic organisms in controlled experimental conditions. Microbiological studies examine minimum inhibitory concentrations, bacterial resistance patterns, and synergistic effects with other antimicrobial agents. This compound enables researchers to evaluate beta-lactamase stability and cross-resistance mechanisms in bacterial isolates. Pharmaceutical development teams study bioavailability parameters, dissolution profiles, and stability characteristics under different storage conditions.
Research applications extend to pharmacokinetic studies, drug interaction analysis, and formulation optimisation protocols. Scientists examine cefixime’s molecular interactions with bacterial enzymes and membrane proteins to understand resistance development mechanisms. Quality control laboratories utilise this compound for analytical method validation and reference standard preparation. Researchers exploring novel drug delivery systems investigate tablet dissolution behaviour and active ingredient release profiles through comprehensive cefixime research compounds available for laboratory studies.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Cefixime |
| Strength | 250mg per tablet |
| Manufacturer | Lupin |
| Formulation | Dispersible Tablet |
| CAS Number | 79350-37-1 |
| Molecular Formula | C₁₆H₁₅N₅O₇S₂ |
| Molecular Weight | 453.45 g/mol |
| Storage | Room temperature, dry conditions |
Research laboratories require precise documentation and analytical verification for all pharmaceutical compounds used in scientific studies. This cefixime preparation undergoes rigorous quality control testing to ensure consistent potency and purity for reliable experimental results. Investigators studying antimicrobial mechanisms can access additional research compounds through specialised categories including selective androgen receptor modulators and research peptides for comprehensive molecular biology investigations.
Research Compliance Statement
This product is intended exclusively for in-vitro laboratory research purposes by qualified scientific personnel. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must follow appropriate laboratory safety protocols and institutional guidelines when handling pharmaceutical compounds. All experimental work should be conducted in properly equipped laboratory facilities with adequate ventilation and safety equipment.
